To specifically demonstrate the participation of these pathways in tumor cell transmigration across LEC monolayers, we performed transmigration assays using cells treated with the TGFβ-RI kinase inhibitor SB431542, the FAK inhibitor PF-573228, or after the cells had been pre-treated with a blocking antibody against the β3 integrin. This evidence concerns the gene PTK2 and neoplasm.